Market OpportunityThere is a significant market opportunity with an estimated 25,000 to 30,000 adults in the U.S. getting cochlear implants annually by 2026, representing a market opportunity exceeding $750 million.
Product DevelopmentEnvoy has developed the Acclaim CI, a fully implanted cochlear implant that does not require any external component to be worn on the ear.
ValuationThe current valuation is considered attractive, with the potential for significant upside, leading to a maintained BUY rating and an increased 12-month price target to $9.50.